Adage Capital Partners’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.08M Hold
4,500,000
– – 0.01% 820
2026
Q2
$9.4M Hold
4,500,000
– – 0.01% 734
2026
Q1
$7.88M Hold
4,500,000
– – 0.01% 732
2025
Q4
$10.6M Buy
+4,500,000
New +$8.65M 0.02% 654

Other funds holding PALI

Adage Capital Partners's PALI Position: Q3 2026 in Review

Adage Capital Partners held its Palisade Bio (PALI) position steady in Q3 2026 at 4,500,000 shares worth $6.08M. The position accounts for 0.01% of the portfolio, ranked #820.

Adage Capital Partners first reported a position in PALI in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.6M in Q4 2025. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Adage Capital Partners held 4,500,000 shares of Palisade Bio worth $6.08M as of Q3 2026.
  • Adage Capital Partners left its Palisade Bio share count unchanged in Q3 2026.
  • Palisade Bio made up 0.01% of Adage Capital Partners's portfolio in Q3 2026, its #820 holding.
  • Adage Capital Partners first reported a position in Palisade Bio in Q4 2025 and has held it in 4 quarters since.
  • Adage Capital Partners's Palisade Bio position peaked at $10.6M in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.